Oncology Business Management | Specialty

The OncLive Oncology Business Management condition center page is a comprehensive resource for news and expert insights on business-focused updates and topics in oncology practices, including diversity efforts, telehealth, gaps in care, payment models, and more. This page features news articles, interviews in written and video format, and podcasts that focus on updates and best practices with oncology business management.

Experts: No Savings From Smaller Cancer Drug Packages

June 14th 2016

Two researchers have challenged the notion that money can be saved by packaging medications in sizes that conform more closely to patient weight and dosing needs.

Feeling Chafed by Cigna's Genetics Policy

June 13th 2016

Cigna's new policy is an extension of a previous Cigna requirement for the use of certified genetic counselors for breast, ovarian, and colorectal cancer genetic tests.

Patient Longevity Will Be Key Driver in Hematology Market Growth

June 12th 2016

Incoming generic and biosimilar substitutes for dominant, brandname hematology drugs may lead to less costly treatment, but a lot will depend on the quality and supply of these new products,

A Value Proposal That Will Raise Costs

June 11th 2016

It seems to be that there is a "minor" disagreement between ASCO and CMS about the approach to address value in cancer care delivery.

Florida Practices Band Together for Strength

June 9th 2016

Florida Cancer Specialists & Research Institute has honed its merger strategy into a finely tuned regimen that goes from due diligence to planning to implementation and follow-up, all in a period as short as 120 days.

Reduce Exposure to Financial Risk With a Financial Counseling Program

June 8th 2016

A well-tailored financial counseling program can help a practice minimize exposure to financial risks due to increasing patient responsibility.

Global Oncology Drug Spending Reaches $107 Billion

June 2nd 2016

The global cost of cancer therapies shot up to $107 billion in 2015, an 11.5% rise from the $100 billion 2014 total for oncology therapeutics and supportive care drugs.

Direct Contracting Is the Key to Bypassing the Payer

June 1st 2016

Under direct contracting, a provider signs an agreement with a business or membership organization outlining the care to be provided and the payment scheme, cutting out the insurer completely.

CMS Puts On Its Poker Face

June 1st 2016

The saying on Wall Street is "sell in May and go away," but there's no detaching from the cliffhanger that CMS has left in the air.

New Blockbusters Will Offset Generic Price Erosion in Hematology

May 31st 2016

Hematological practices can expect a slate of new generics to replace long-established brand drugs going off patent, as well as new blockbuster blood therapies that will significantly improve the treatment of some malignancies.

ABIM Offers a Less Burdensome Path to Maintenance of Certification

May 18th 2016

The American Board of Internal Medicine has promised to roll out a series of short assessments that could potentially be taken in the privacy of one’s home or office and via an open book exam.

Changing Drug Packaging Won't Eliminate the Waste

May 17th 2016

Two researchers have challenged the notion that money can be saved by packaging medications in sizes that conform more closely to patient weight and dosing needs.

FDA Approves Lenvatinib/Everolimus for Advanced RCC

May 13th 2016

The FDA has approved the combination of lenvatinib and everolimus as a treatment for patients with advanced renal cell carcinoma (RCC) following prior antiâ€“angiogeneic therapy

More Data Needed to Eliminate the Guesswork In Using Evidence Blocks

May 11th 2016

The Evidence Blocks developed by the National Comprehensive Cancer Center make up one of the most ambitious attempts so far to incorporate data from multiple platforms to create a resource with broad applicability for the healthcare community.

Employers Say That Value Means Working Directly With Oncology Providers

May 10th 2016

Oncology practices may soon find themselves working directly with employers on benefits and treatment strategies.

Unionized Town Simplifies Management for Nevada Practice

May 8th 2016

Comprehensive Cancer Centers of Nevada's exponential expansion is, in part, a result of both the surging local headcount and the national trend toward oncology practice consolidation.

Capitol Hill Fight Against Medicare Rule Change Gathers Steam

May 5th 2016

Members of Congress on both sides of the aisle have responded to urgings from the oncology sector that they join in the effort to quash a proposal to change the rule on physician pay under Medicare Part B.

FDA Grants Blinatumomab Priority Review for Pediatric Acute Lymphoblastic Leukemia

May 4th 2016

The FDA has granted a priority review to an application to expand the approval of blinatumomab (Blincyto) to include the treatment of pediatric and adolescent patients with Philadelphia chromosome-negative relapsed or refractory B-cell precursor acute lymphoblastic leukemia.

Some Prefer Pay Cuts to Inflexible CMS Metrics

May 2nd 2016

For most oncologists at Texas Oncology, healthcare quality reporting to the CMS went smoothly, but serious complications were encountered.

Enzalutamide Pricing Debate Goes to Washington

May 1st 2016

Enzalutamide (Xtandi) pricing heightens the likelihood of pre-authorization requirements and cost-sharing arrangements that may be financially burdensome, ruinous, or simply impossible to meet.